InvestorsHub Logo
icon url

scalpel

10/02/17 3:01 PM

#59819 RE: DRG1025 #59816

Realizing that I am not a big T, I am going to throw in my proverbial two cents:

Many have postulated that the overhanging issue of financing is what is keeping the stock price down. This is overly simplistic. I think the issue is not "the financing" but the concern that we will need to raise more funds through a public offering at a low PPS which will significantly dilute the outstanding share base.

If we can raise the price organically, another offering would not be as dilutive. However, it would be inherently better if we can raise funds through warrant conversion, which while dilutive, would add more shares that are already baked into the current price.

Both of these options would be much better for "morale", e.g. share price.
icon url

EIT

10/02/17 4:07 PM

#59824 RE: DRG1025 #59816

IMO...This stock will go up much more when its recognized as a player in the field. It never really has been, and for a short while it was a few years ago, all confidence was squandered pretty quickly. That's why the Nicholson news was so important, as well as the signing on of McNally as legitimate player as opposed to previous management.

It's also the financing or dilution still needed, which I always thought was the principal factor in suppressing PPS, but since McNally has made some very positive changes, I think the above is actually the bigger factor here.

There's also some other important upward momentum that's easily forgotten, which is that we're getting pretty close to FDA submission, and it's starting to look like they will make it according to timeline. In 2014, that anticipation led to a fivefold increase in PSS over one year, despite dilution happening at the time, and without any real news (or visible product).

That could easily happen again provided they make the timelines and confidence increases in that period. So, a much higher PPS over the coming year seems quite feasible to me despite dilution, because this time there's so much more supporting this stock (like an actual product that is well-received)
icon url

BigT82

10/02/17 6:14 PM

#59828 RE: DRG1025 #59816

Sorry, been a busy day. Was not able to check in most of the day but saw we ended higher. There are many reasons I believe we are going higher and, perhaps, will be much higher by the end of the year. This is not based on stock fundamentals or technical analysis, this stock does not trade off those anyway. This is purely a belief based on where we are at as a pre revenue R&D company that really has not had much good news (outside of Mac and team being hired) in years, until now! We have hit rock bottom folks, the turnaround begin in January with Mac. Things had to get worse before they could get better. I'm all in for the ride back up which could be very quick should all milestones be met, funding addressed, more and more news from the 3 sights and surgeons using SPORT, and who knows, maybe even a few very pleasant and unscheduled surprises. I sure feel like the risk is to the upside now and not worried about seeing 10 cents again. I'll load one more time if this trickles down to 20 or I'll just let it all ride should we clear 30 soon and never look back. Our patience is and will pay off!